The short version: This is my 2019 Psychedelics Today podcast conversation about Salvia divinorum. We talk less about pharmacology and more about what the research suggests regarding consciousness, embodiment, and the relationships people form with plants and substances. It’s a discussion of research and ideas, not clinical or safety advice.
A researcher spends years studying one unusual plant and comes away with more questions about relationship, to substances, to the body, to other people, than about the plant’s chemistry alone.
That’s roughly where I landed, and it’s what I got to talk about when I joined Psychedelics Today in 2019. Here I am talking about Salvia divinorum again, this time on a podcast. We discussed my research findings and what they might have to do with consciousness, embodiment, and the ways in which we create relationships with plants and substances.
If you’d rather start with the science, how salvinorin A works, why its dissociation-like effects are different from other psychedelics, and what the research does and doesn’t support, that all lives in my main piece on Salvia divinorum in psychotherapy.
Curious about working together? Get in touch.
Peter H. Addy, PhD, LPC, LMHC is a Portland-based licensed psychotherapist specializing in psychedelic-informed and harm-reduction psychotherapy, ketamine-assisted psychotherapy, and chronic pain. His research background includes postdoctoral work at Yale School of Medicine on psychedelic substances. Learn more about my practice →
